Symbols / OCX
OCX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-24 17:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
News
RSS: Latest OCX news- OCX OncoCyte NASDAQ After Hours 23 Feb 2026: $3.20 oversold bounce, watch $3.80 - Meyka Mon, 23 Feb 2026 22
- Oncocyte Exits Irvine, Rebrands as Insight Molecular Diagnostics - Orange County Business Journal ue, 17 Jun 2025 07
- Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville - GlobeNewswire ue, 17 Jun 2025 07
- Oncocyte (OCX) Gains Favorable Reimbursement for GraftAssureCore Test | OCX Stock News - GuruFocus Wed, 21 May 2025 07
- RTX Delivers GPS Ground Control Network to Space Force After Years of Delay - Bloomberg.com hu, 17 Jul 2025 07
- OncoCyte’s (OCX) Stock Rises With New Diagnostic Product and Promising Partnership. - Nasdaq Wed, 24 Jul 2024 07
- 3 Trending Biotech Penny Stocks - 24/7 Wall St. hu, 22 Aug 2024 07
- Raytheon Wins $15 Million Modification for Next Generation OCX Contract Support - Security Clearance Jobs ue, 07 Mar 2023 08
- There Can Be Only One: David Downey and OneChicago Stand Alone - WatersTechnology.com Wed, 05 Oct 2011 07
- Is OncoCyte (NYSEMKT:OCX) Weighed On By Its Debt Load? - simplywall.st hu, 22 Oct 2020 07
- Ocean Biomedical signs $32M pact with Polish biotech for preclinical YKL-40 inhibitors - Fierce Biotech ue, 15 Oct 2024 07
- 10 ETFs to Buy to Mimic 2021’s Best Stock Picks - InvestorPlace Wed, 24 Feb 2021 08
- IMDX Stock Price, News & Analysis - Stock Titan Wed, 18 Jun 2025 04
- A Startup Offers a New Vision for Trading Across Different Markets - WSJ Sun, 23 Sep 2018 07
- Raytheon Whistleblower Obtains $1M in Special Damages in Defense Contractor Whistleblower Protection Case - The National Law Review Mon, 02 Dec 2019 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for OCX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|